Avantor Featured Articles

1. Peristaltic Pump Configuration Saves Days Of Production Time 11/14/2024

   Explore how a molecular biology client improved their fill-finish efficiency by configuring a peristaltic pump, reducing fill time, minimizing agitation, and saving significant technician time annually.

2. Advancing Clinical Trials Manufacturing From Pilot To Production 10/16/2024

   Scaling manufacturing of clinical trial materials requires careful planning to ensure flexibility and compliance with quality standards. Explore essential strategies to advance production and sample management.

3. Pre-Use Post Sterilization Integrity Testing (PUPSIT) 10/8/2024

   Explore how, when, and why pre-use post sterilization integrity testing (PUPSIT) should be used and how to navigate the complexities of filter integrity testing.

4. Overcoming Efficiency And Quality Challenges In Gene Therapy Development 10/8/2024

   Review the importance of collaboration and innovation in addressing the challenges with scaling up gene therapy production, from adopting new cell lines to integrating AI in process optimization.

5. Key Drivers To Overcome Obstacles In mAbs Formulation And Fill-Finish 7/11/2024

   Discover the key strategies to overcome, aided by comprehensive support from suppliers, to streamline the formulation and fill-finish process and deliver effective mAb therapies on time.

6. Single-Use Technologies: Trends And Top Tips For Making The Switch 7/11/2024

   Single-use technologies are an integral and rapidly growing part of the bioprocessing manufacturing landscape. Take a look at trends in single-use, plus top tips for making the switch.

7. Designing For Full cGMP Production At Pilot Scale 6/17/2024

   Explore how early adoption of fully compendial, cGMP raw materials can provide a return on investment by reducing steps in your process and potential yield losses and avoiding lost production time. 

8. Novel Cell Lysis Solution: Scaling Up The Harvest Process 5/10/2024

   To ensure patient safety — as well as a portable process outside of Europe — it’s time to find a novel reagent without harmful, endocrine-disrupting properties.

9. Address Current Challenges In Gene Therapy Viral Vector Manufacturing 4/16/2024

   This article addresses key advancements at each step in the production of viral vectors — from maximizing titer output at scale upstream to optimized formulation compositions at fill/finish — to support commercial scale.

10. Meeting Local Regulations With Ready-To-Use Buffer Solutions 1/22/2024

    Learn about a ready-to-use, custom buffer solution provided to a biopharmaceutical manufacturing facility in order to help them reduce costs and the amount of time spent on QC testing and validation.